RETO:NASDAQReTo Eco-Solutions, Inc. Analysis
Data as of 2026-04-28 - not real-time
$0.66
Latest Price
9/10Risk
Risk Level: High
Executive Summary
ReTo Eco‑Solutions trades at $0.664, far below its DCF‑derived fair value of $13.50, implying a dramatic discount (over 95% undervaluation). However, the company posts zero earnings per share, a negative operating margin of -133%, and a distressing debt‑to‑equity ratio of 5.79, indicating severe profitability and balance‑sheet challenges. Technical signals are mixed: the 20‑day SMA (0.876) sits above the current price, the 50‑day SMA (0.831) is also higher, and the MACD histogram is negative, suggesting short‑term bearish momentum, while the RSI of 42 points to a neutral stance. Volatility is extreme at 225% over 30 days and beta 1.42, highlighting a highly risky price profile, and the stock’s market cap is only $8 million with increasing but still modest volume, raising liquidity concerns. The recent acquisition of a majority stake in Seven Arrows Supply Chain Limited could provide a strategic foothold in logistics and potentially improve cash flows, but its impact remains uncertain. Given the combination of massive valuation gap, weak fundamentals, high volatility, and limited liquidity, the stock is best viewed as a speculative play with upside only if the acquisition translates into sustainable earnings.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD histogram and price below short‑term SMA
- Negative operating margin and zero EPS
- High short‑term volatility (225% 30‑day) and liquidity constraints
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from Seven Arrows acquisition
- Extreme valuation discount versus DCF fair value
- Continued balance‑sheet strain and high debt levels
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value suggests massive upside if profitability improves
- Strategic acquisition could unlock new revenue streams
- Current price offers a deep margin of safety for long‑term investors willing to bear high risk
Key Metrics & Analysis
Financial Health
Revenue Growth36.60%
ROE-38.33%
ROA-8.33%
Debt/Equity5.79
P/B Ratio0.0
Op. Cash Flow$6.2M
Free Cash Flow$-3822634
Technical Analysis
TrendNeutral
RSI42.3
Support$0.48
Resistance$1.57
MA 20$0.88
MA 50$0.83
MA 200$4.30
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
Fair Value$13.50
GradeUndervalued
TypeValue
Risk Assessment
Beta1.42
Volatility225.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.